期刊文献+

咪唑斯汀联合西替利嗪递减疗法治疗慢性荨麻疹疗效观察 被引量:1

Effect Observation of Decremental Therapy with Mizolastine Combined with Cetirizine for the Treatment of Chronic Urticaria
下载PDF
导出
摘要 目的观察咪唑斯汀联合西替利嗪递减疗法治疗慢性荨麻疹疗效。方法将入选的80例患者按就诊时间顺序随机分为两组,试验组40例,对照组40例。试验组:第一、二周早餐后咪唑斯汀10mg,睡前西替利嗪10mg。第三、四周第一天睡前咪唑斯汀10mg,第二天睡前西替利嗪10mg。第五、六周第一天睡前咪唑斯汀10mg,第二天停药,第三天睡前西替利嗪10mg。对照组:每日睡前服咪唑斯汀10mg,共6周。停药4周后观察复发情况。结果 6周结束后试验组有效率为90.00%,对照组有效率为92.5%,两组差异无统计学意义(P>0.05),复发率试验组(35%)明显低于对照组(50%)。结论咪唑斯汀联合西替利嗪递减疗法治疗慢性荨麻疹疗效满意,又能降低复发率,值得临床进一步探讨。 Objective To observe the effects of decremental therapy with mizolastine combined with cetirizine for the treatment of chronic urticaria.Methods 80 patients selected according to the clinical time sequence were randomly divided into two groups:experimental group(40 cases),control group(40 cases).In experimental group the patients were taken the mizolastine 10 mg after breakfast and cetirizine 10 mg before bedtime in the first,second week;mizolastine 10 mg before bedtime of the frist day and cetirizine 10 mg before bedtime of the second day in the third,forth week;mizolastine 10 mg before bedtime of the frist day,no drugs in the second day,cetirizine 10 mg before bedtime of the third day in the fifth,sixth week.In control group the patients were taken the mizolastine 10 mg before bedtime everyday for 6 weeks.The disease was observed after 4 weeks of stoping to be given drugs.Results The effective rate was 90% in experimental group and 92.5% in control group respectively after 6 weeks,there was no statistically significance difference in the two groups(P0.05);the recurrence rate of experimental group(35%) was obviously lower than that of control group(50%).Conclusion Decremental therapy with mizolastine combined with cetirizine for the treatment of chronic urticaria has satisfactory effects and can reduce the recurrence rate,which deserves to be deeply explored.
作者 陈晓芬
出处 《临床医学工程》 2010年第8期3-4,共2页 Clinical Medicine & Engineering
关键词 慢性荨麻疹 递减疗法 咪唑斯汀 西替利嗪 Chronic urticaria Decremental therapy Mizolastine Cetirizine
  • 相关文献

参考文献3

二级参考文献11

  • 1张宏誉,李宏,岳凤敏,王良录,方权,王瑞琦,秦万章,李明,金岚,秦立模,吴惠俐.咪唑斯汀治疗慢性特发性荨麻疹的多中心随机平行组对照的临床试验报告[J].中华微生物学和免疫学杂志,2001,21(S2):61-64. 被引量:11
  • 2郑虎.药物化学[M].5版.北京:人民卫生出版社,2005:80-91.
  • 3赵辨.临床皮肤病学[M].3版.南京:江苏科学技术出版社,2002:112.
  • 4Pichat P;Angel I;Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat,1998(01).
  • 5Benavides J;Schoemaker H;Dana C.In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent,1995.
  • 6Dubertr;Murrieta Aguttes M;Tonet J.Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria:results of the MILOR Study[J],1999.
  • 7Sabbah A;Daele J;Wade AG.Comparison of the efficacy,safety,and onset of action of mizolastine,cetirizine,and placebo in the management of seasonal allergic rhinoconjunctivitis.MIZOCET Study Group[J],1999.
  • 8Leynadier F;Duarte-Risselin C;Murrieta M.Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria URTILOR study group,2000.
  • 9朱大勋.咪唑斯汀和四种常用H_1受体阻滞剂的实验抗组胺强度比较[J].中华皮肤科杂志,2001,34(3):219-220. 被引量:36
  • 10郭在培,张谊之,冉玉平,刘宏杰.咪唑斯汀(皿治林)治疗慢性荨麻疹35例疗效观察[J].临床皮肤科杂志,2001,30(6):379-380. 被引量:23

共引文献161

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部